Prescription Drugs - Cameroon

  • Cameroon
  • In Cameroon, the revenue in the Prescription Drugs market is estimated to reach US$78.00m in 2024.
  • It is projected to have an annual growth rate (CAGR 2024-2029) of 3.50%, leading to a market volume of US$92.64m by 2029.
  • When compared globally, United States is expected to generate the highest revenue with US$358.90bn in 2024.
  • Taking into account the total population figures, per person revenues of US$2.65 are anticipated in Cameroon in 2024.
  • Cameroon's prescription drug market is experiencing a surge in demand for affordable generic medications due to rising healthcare costs.

Key regions: Japan, China, Europe, Australia, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Cameroon has been experiencing significant growth in recent years.

Customer preferences:
Cameroonian customers have shown a growing preference for prescription drugs, leading to an increase in demand for pharmacies. This can be attributed to several factors, including an aging population, the rising prevalence of chronic diseases, and a growing awareness of the importance of healthcare. As a result, more individuals are seeking medical treatment and relying on prescription drugs to manage their health conditions.

Trends in the market:
One notable trend in the Prescription Drugs (Pharmacies) market in Cameroon is the increasing number of pharmacies. This can be attributed to the government's efforts to improve access to healthcare services across the country. The government has implemented policies to encourage the establishment of pharmacies in underserved areas, resulting in a greater presence of these establishments in rural and remote regions. Additionally, there has been a rise in the number of online pharmacies, allowing customers to conveniently purchase prescription drugs from the comfort of their homes. Another trend in the market is the growing popularity of generic drugs. Generic drugs are more affordable compared to their branded counterparts, making them an attractive option for cost-conscious customers. The availability of generic drugs in pharmacies has increased, leading to a shift in customer preferences towards these more affordable options. This trend is further supported by the government's initiatives to promote the use of generic drugs as a means to reduce healthcare costs.

Local special circumstances:
Cameroon faces unique challenges in the Prescription Drugs (Pharmacies) market. One such challenge is the limited healthcare infrastructure in certain regions, particularly in rural areas. This poses difficulties in terms of access to pharmacies and prescription drugs for individuals residing in these underserved areas. The government is working to address this issue by implementing programs to improve healthcare infrastructure and increase the availability of pharmacies in these regions. Another special circumstance is the presence of counterfeit drugs in the market. Counterfeit drugs pose significant risks to public health and safety, as they may contain incorrect ingredients or incorrect dosages. The government has taken steps to combat the issue by implementing stricter regulations and conducting regular inspections of pharmacies to ensure the authenticity and quality of prescription drugs.

Underlying macroeconomic factors:
The growth of the Prescription Drugs (Pharmacies) market in Cameroon is also influenced by underlying macroeconomic factors. The country has experienced steady economic growth in recent years, resulting in an increase in disposable income levels. This has allowed individuals to allocate a larger portion of their income towards healthcare expenses, including the purchase of prescription drugs. Additionally, the government's commitment to improving healthcare infrastructure and access to healthcare services has further contributed to the growth of the market. In conclusion, the Prescription Drugs (Pharmacies) market in Cameroon is developing due to customer preferences for prescription drugs, the increasing number of pharmacies, the popularity of generic drugs, and the government's efforts to improve healthcare infrastructure. However, challenges such as limited healthcare infrastructure in certain regions and the presence of counterfeit drugs need to be addressed to ensure the continued growth and development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)